Subjective and objective markers for plateau include diminishing benefits after initial improvements, requiring higher doses for same effects, increased side effects relative to benefits, and biomarkers stopping improvement despite continued use
In vitro studies demonstrated that AOD-9604 can directly stimulate lipolysis in isolated human adipocytes, though the potency was lower than native GH or synthetic lipolytic agents like epinephrine or isoproterenol
Individuals seeking weight loss should be directed towards evidence-based interventions including dietary modification, increased physical activity, and behavioural support
Exogenous growth hormone inhibits growth hormone-releasing factor-induced growth hormone secretion in normal men
However, for drug delivery, the mucosal barrier has become an important limiting factor